Anti-CD134 (OX40) (Humna) mAb, IgG2a, Clone: W4-3, Rat, Monoclonal, Rt

Artikelnummer: MBL-D125-3
Artikelname: Anti-CD134 (OX40) (Humna) mAb, IgG2a, Clone: W4-3, Rat, Monoclonal, Rt
Artikelnummer: MBL-D125-3
Hersteller Artikelnummer: D125-3
Alternativnummer: MBL-D125-3
Hersteller: MBL
Wirt: Rt
Kategorie: Antikörper
Applikation: FACS
Spezies Reaktivität: Hu
Immunogen: Human OX40 transfectant
Alternative Synonym: ACT35, ACT35 antigen, ATC35 antigen, CD134, CD134 antigen, IMD16, Ly-70, lymphoid activation antigene ACT35, Ox40, OX40 antigen, OX40 cell surface antigen, OX40 homologue, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, tax-transcriptionally activated glycoprotein 1, tax-transcriptionally activated glycoprotein 1 receptor, tumor necrosis factor receptor superfamily member 4, Txgp1, TXGP1L
Anti-CD134 (OX40) (Humna) mAb, IgG2a, Clone: W4-3, Rat, Monoclonal, Rt
Anti-CD134 (OX40) (Humna) mAb
Klonalität: Monoclonal
Konzentration: 1 mg/mL
Klon-Bezeichnung: W4-3
Isotyp: IgG2a
NCBI: 22163,7293
Quelle: This antibody was purified from C.B-17 SCID mice ascites fluid using protein A agarose. This hybridoma (clone W4-3) was established by fusion of mouse myeloma cell SP2/0 with WKA/H rat splenocyte immunized with the human OX40 transfectant.
Formulierung: 100 µg IgG in 100 µl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained.
Lagerung: -20°C
Formel: 100 µg IgG in 100 µl volume of PBS containing 50% glycerol, pH 7.2. No preservative iscontained.
Target-Kategorie: OX40/CD134
Kommentar: For Research Use Only. Not for use in diagnostic procedures.
Application Verdünnung: FCM: 10-20 µg/mL (final concentration)
Anti-CD134 (OX40) (Humna) mAb